Site-specific incorporation of biotinylated amino acids to identify surface-exposed residues in integral membrane proteins  by Gallivan, Justin P. et al.
Research Paper 739 
Site-specific incorporation of biotinylated amino acids to identify 
surface-exposed residues in integral membrane proteins 
Justin P Gallivanl, Henry A Lester2 and Dennis A Dougherty’ 
Background: A key structural issue for all integral membrane proteins is the 
exposure of individual residues to the intracellular or extracellular media. This 
issue involves the basic transmembrane topology as well as more subtle 
variations in surface accessibility. Direct methods to evaluate the degree of 
exposure for residues in functional proteins expressed in living cells would be 
highly valuable. We sought to develop a new experimental method to determine 
highly surface-exposed residues, and thus transmembrane topology, of 
membrane proteins expressed in Xenopus oocytes. 
Results: We have used the in Go nonsense suppression technique to 
incorporate biotinylated unnatural amino acids into functional ion channels 
expressed in Xenopus oocytes. Binding of ‘251-streptavidin to biotinylated 
receptors was used to determine the surface exposure of individual amino 
acids. In particular, we studied the main immunogenic region of the nicotinic 
acetylcholine receptor. The biotin-containing amino acid biocytin was efficiently 
incorporated into five sites in the main immunogenic region and extracellular 
streptavidin bound to one residue in particular, ~270. The position of (x70 as 
highly exposed on the receptor surface was thus established. 
Conclusions: The in viva nonsense suppression technique has been extended 
to provide the first in a potential series of methods to identify exposed residues 
and to assess their relative exposure in functional proteins expressed in 
Xenopus oocytes. 
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Introduction 
Dctcrmining the trdnsmembrane ropolog_v of integral mem- 
brane proteins such as ion channels and neurotransmitrer 
rransporters is a nccessq first step in c\aluating their 
swwurc and function at rhe molecular Iwel [l]. I\fter the 
topology has been established, a more demanding clues- 
tion is the rclarivc exposure of individual residues to the 
intracellular or extracellular media. Knowledge of tmns- 
mcmbranc ropolog) and cxposurc allows one to identify, 
regions of a protein that ma)- bccomc glycos+ted or form 
binding sites for external ligands, to identify intracellular 
regions that may be subject to phosphorylation, to assign 
potential binding sites for other intracellular seconder) 
messengers (such as G protcins), and to make predictions 
regarding the olwall strucrurc and function of an integral 
mcmbranc protein. 
‘I‘he prcsenr stud?; addresses the ‘higher resolution’ issue of 
surface exposure. \Z’e wished to determine which residues 
are clearly on the ‘outside’ surface of a receptor. Of course. 
if ;I residue is determined to be exposed then the topolog) 
question is ansu-cred. Kcsidue accessibility is clearly a 
rclat-ed mcasurc of protein structure. but, as discussed 
below. it addresscs 3 somewhat different issue. Here, \vc 
consider a rclrrti\+ Lvell-understood membrane protein, 
the nicotinic acetylcholinc receptor (nAChR). ‘I’hcre is gen- 
eral agreement concerning the overall topology of this 
receptor. although final proof will rcquirc high-resolution 
strwwral data. Each subunit is thought to hale a large, 
cxtracellular amino-terminal domain, followed by four trans- 
membrane regions and a necessarily extracellular carbos~-l 
t-erminus (Figure la). Little is known about the rclatiw 
exposures of residues throughout the receptor, however. 
hlan)- other mcmbranc channels, transporters, and reccp- 
tars ha\.e less v ell-understood topologies. The first step 
(and. unfortunately, often the last step) in dcrermining the 
topology is rhe generation of a hydropathy plot based on 
the protein sequence. Xlthough hydropathy plots arc use- 
ful in suggesting a possible t-opolog) for 11 mcmbranc 
protein, the) arc by no means an effcctile snbstiwtc for 
experimental cvidencc. For instance, the primaq amino- 
acid sequence for the ionotropic glutamate receptor was 
first determined in 1989 and Icd to a topological model 
analogous to that for the nicotinic receptor - four trzms- 
membrane domains and cx~racellularl~ located amino and 
carboxyl tcrmini [2]. Subscqnent work showed that the 
putative second transmembrane domain is likely to form a 
reentrant loop. so that the amino and carboxy tcrmini arc 
on the opposite sides of the membrane (Figure lb) [.3,4]. 





The topology of the nicotlnic acetylcholine 
receptor (nAChR) and glutamate receptor 
(GIuR3). (a) The generally accepted topology 
of each subunit of the nAChR. This is also the 
Chemstry & B,ology COOH 
onginal topology model (1989-l 995) 
proposed for GluR3 [2]. (b) The revised 
topology for the glutamate receptor [3,41. 
Such a drastic change certainly alters one’s view of the 
structure and mode of action of the receptor. Other recent 
experiments on a variety of ion channels and transporters, 
including the potassium channel ROn!lKl [S], the GAHA 
transporter GAT-1 [h], the glycine transporter GI,Y’I’l [7], 
and the Na+/glu~osc co-transporter SGL’I’l (81, have sug- 
gested inconsistencies in the transmembranc topologies 
predicted from hydropathy analysis. 
‘These studies underscore the importance of having defini- 
tive experimental approaches to determine the transmem- 
brane topology of mcmbranc proteins. Although several 
methods are available, a new approach would be welcome 
if it could overcome some of the inherent weaknesses of 
the existing methods. 
Approaches for determining topology/accessibility 
A wide variety of techniques have been dcvelopcd to 
address the topology issue [l]. Below, wc briefly describe 
some of the higher precision approaches that target specific 
regions of integral membrane proteins. 
Endogenous glycosylation sites and N-glycosylation scanning 
mutagenesis 
One of the most common methods for determining trans- 
membrane topology is to assay a particular region of a 
protein for endogenous N-linked glycosylation. Because 
N-linked glycosylation occurs on the luminal side of the 
endoplasmic reticulum, with few exceptions [9] only 
regions destined to become extracellular are glycosylated. 
‘Thus, identifying a site that is glycosylated in the wild-type 
protein is good evidence that it is located extracellularly. 
Expanding upon this tactic, one can engineer N-linked 
glycosylation sites into transmembrane proteins to deter- 
mine topology. ‘This approach has been used recently to 
assay the transmembrane topologies of many ion channels 
and transporters, including GATI [6], GLYTI [7], CFTR 
[lo], and SGL’I‘l [Xl. In all these studies, the functional 
compctencc of the glycosylated mutants was often quite 
poor compared with that of the wild-type protein and in 
many cases the modified proteins did not function at all. 
‘I-his is of particular concern because the introduction of a 
non-native glycosylation site may alter topology [4]. If a 
particular protein is found to bc glycosylated in the experi- 
mcnt but does not function, it is often difficult to determine 
whether the protein fails to function because glycosyla- 
tion interferes with the normal function of the protein or 
because glycosylation has caused the protein to fold lvith 
an altered topology. 
Cysteine accessibility/substituted-cysteine accessibility 
Another common method for determining transmembrane 
topology is the introduction of cysteine residues into the 
protein of interest, followed by labeling with thiol-reactive 
reagents. If the reagent is membrane-impermeant, topol- 
ogy can be evaluated by comparing the results of intracel- 
lular versus extracellular application [ll,lZ]. For example, 
cystcines have been modified with biotin-containing 
reagents, and the reaction detected by streptavidin 
binding [ 13,141. ‘I’he cysteine modification approach has 
an advantage over glycosylation methods in that a single 
cysteine mutant is often less perturbing to the overall 
protein structure than the introduction of a glycosylation 
site. The method has been generalized by Karlin and 
coworkers [15,16] to the substituted-cystcine accessibility 
method (SCAM). allowing the ‘accessibility’ of specific 
residues to be probed with relatively small thiol-reactive 
reagents. Note that such accessibility is quite different 
from ‘exposure’ as used here. SCAM has labeled residues 
that nominally lie in a trdnsmembrane region, but which 
arc nonetheless accessible because they lie along an ion 
channel or within an agonist-binding site. Potential disad- 
vantages of these methods arise from the contributions of 
endogenous cysteine residues that may also be labeled in 
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the assay. In addition. the introdwtion of new cyst&es 
ma>- Id to improper disulfide bond formation and incor- 
rectly folded proteins. A possible solution to these prob- 
Icms is to mutate all the endogcnous cystcines to another 
amino acid and then to introduce a unique cysteine. ‘I’his 
ha< been suxcssft~l in some proteins, but there arc cer- 
tainly cases v.herc rcmo\d of all the endogenous cysteincs 
u.ill render the protein nonfunctional. l;urthcrmorc, for an 
it/ t,i.w assa)-, there may bc complications arising from 
rcactiw cysteines found in endogenous cellular proteins 
that cannot bc mutated away. 
Epitope protection 
In this type of assay, a fusion is created betaccn the 
protcin of interest and a lvell-defined epitope that is 
rccogniscd by ;I spwific antibody [-i,17.18]. ‘I’he fusion 
proteins arc synthcsiLeci it/ rit1-o in the presence of micro- 
somal \,esicles so that the expressed protein is inserted 
into the membrane. Digestion of the translation mixture 
with protcases cleaves extramicrosoiiial (cytoplasniic) 
regions, destroying the epitope if it is displayed in this 
region. If the cpitopc is located inside the \xsicle, it is 
protected from proteasc digestion and can be immtino- 
precipitated or dctectcd in a Lvestcrn immiinoblot. ‘I’hcre 
are scceral concerns raised hy this assay. hobuw. ‘I’he 
assay is pcrformcd in ;I cell-free system and the topology 
ma> not. thcrcforc, be identical to that in an intact ccl1 
[l Xl. ‘I’he epitope introdwul is often quite large (the pro- 
Iactin epitope is 1% amino acids) and consecliicntl~- must 
often be introdticcd as 2 carboxy-terminal fusion to ;I 
truncated and often non-functional protein [A]. Finally. 
there is dbxys a concern that the introduction of a large 
cpitopc may c~tisc the protein of intcrest to fold imlprop- 
cd\. ‘I‘his potential problem, coupled with the fact that 
the proteins often cannot Ix assayed for function, makes 
the assay less attracti\c 
Tyrosine iodination 
1.cry recently. Hucho and unvorkers 1191 used lJi1 label- 
ing to probe surface exposure of tyrosine residues of the 
nicotinic receptor bar\-csted from 7h/;p&1 u//$iimiu/. ‘This 
mcthod has some attracti\ e futures, but, because all 
exposrd tyrosincs arc labeled simultancotisl~, one must 
wqucnce the labeled protein to determine cxpostire. 
‘I’his is not feasible with proteins for which there is not a 
plentiful natiiral sotircc. 
The biocytin approach 
‘1‘0 address the potential shortcomings of the methods 
uvailablc at present. MY sought to develop a new esperi- 
mental approach to disco\ er surface-cxposcd residues. 
Our &sign goals wcrc: as follows: to determine the surface 
c~l~osiire/topolo~~ of a protein i/r y,&: to assay functional 
protcins \vith wild-type behavior: to introduce a single, 
minimally perturbing mutation: to LISA ;I marker that is 
endogcnous neither to the [prowin of interest nor to other 
cell-surface proteins; to dctcct the marker using robust 
and readily a\ ailable methods; and to produce a graded 
series of reagents that allou conclusions about relati\,e 
exposures. As ;I first step. wc ha\-c combined two com- 
monl!- uscd assay components: the biotin-strclxi\ idin 
interaction and the i/l .z;.cI, nonsense suppression method. 
Kiotin i\ a small ~iiolcct~le that binds \z ith high affinit! 
(I(, -10-l’ hl) to strepa\ idin, ;I 60 kl>a tetrameric protcin. 
Biotin can bc readil) functionalized at its carboxy tcrm- 
nus while retaining its ability to bind tightI!- to strcpt- 
a\idin, rendering it an idul probe [X-221. Uic~tin~lated 
amino acids haw prc\ iotisly been incorporated into pro- 
wins iI/ yif/fi b) supplcmcntinx cr the translation niixturc 
with full-length Iysvl-t1iN.A functionalizcti \vith biotin 
dcri\ ;ltircs at the E-amino group of I\sine. thlls Icading to 
random incorporation of biotinvlatcd amino acids at 
various Iysinc sitcs in the protein [2.X]. :Vthough this sug- 
gestcd that hios\nthetic incorporation cd’ hiotinvlatcd 
amino acids v;\s possible. the remaining challcngc \\ as to 
introduce the biotin label site-slxcifically in the protein of 
intercst in a li\ing cell. ‘I‘0 accomplish this L\.C eniplo~etl 
the nonsicnsc suppression method for incorporation of 
unnatural amino acids into proteins [LA-271, as adapted in 
our laboratories for the i/l ENDOW hetcrologous cuprcssion 
s)stcm of the xmp//.s oocytc [2X-.3,3]. 
In the iu i,i20 nonscnsc suppression method, the oocytc is 
co-injected with t\vo mutated RSA species: niRK:1 syn- 
thesizcd ir/ i>it/n from a mutant c1)N.A clone containing ;L 
stop codon (‘I’.\<;) at the amino acid position of interest, 
and 21 suppressor tKKA that contains the complenicnt:ir\~ 
uti-codon sequence ((:ITA) and has the tiesircd unnat- 
ural amino acid chcmicall! aqlated to the 3 end. I)uring 
transkition hy the oocyte’s synthetic niachincr), the un- 
natural amino acid is specifically incorporated at the posi- 
tion in the protein encoded II! the niRNLA. Recent 
studies in our laboratories ha\-c sho\vn that this method is 
broadl) applicable, txin, 0 compatible \Vith manv diffcrcnt 
proteins, a Isrgc numb3 of situ in 3 xi\ cn protein, and ;i 
~1 idc range of Lmiino acids. 
As 3 test amino xid 1f.c chose biocytin (Figure 7), a n;itu- 
rally occurring (but not translationall~- incorporated) biotiny- 
latcd amino acid. Hioc! tin’s relativcl) small six, similarity 
to the natural amino acid lysinc, and commercial a\xilabil- 
it? made it partictilarl\ attrncti\c ‘1’0 tat the bioc\tin 
method, WC chose the prototype ligand-ptcd ion channel. 
the n:\ChK, a 290 kDa pcntamcric ion channel found at 
the neuromuscular junction (Figure 3) [34-.3X]. In prticu- 
lar, \ve chose to c\2ltintc the main immiinogcnic region 
(RIIR) of the a subunit. ‘1%~ 1IIR is composed of ten 
residues in the ~imino-terminal region of the a subunit 
(rcsidtics 67-76: 0X17-76) and hinds man) antilxdics. 
including those associated \vith myasthcnia gxris, a human 
aiitoinimunc discasc [.YMl]. Fiirthcrmorc. this region has 
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Figure 2 
The structure of biocytln, a naturally occurring (but not translationally 
incorporated) amino acid. 
been shown by electron microscopy to be located near the 
synaptic end of the nAChR [42]. Because it is known to be 
topologically extracellular and accessible as a unit to large 
proteins, the MIR appeared to be an ideal location to test 
the biocytin methodology for evaluating the surface expo- 
sure of individual residues. Given the tight fit between 
biotin and streptavidin, we anticipated that only the most 
highly exposed positions of the ;\IIR would form strong 
biocytin/streptavidin complexes. 
Results and discussion 
We first mutated the codons for each of the ten residues of 
the MIR of the nAChR from mouse muscle (~~67-76; see 
Table 1 for sequence) to the stop codon ‘I’AG. We then co- 
injected Xeno$us oocytes with a mixture of mutant mRiYA 
(1.2 ng total/oocyte; 4:l:l:l a:P:y:6 subunit stoichiometry) 
containing the TAG codon at a single position in the a 
subunit and an aminoacyl-tRNA (25 ng/oocyte) charged 
with the amino acid of interest. After 3648 h, oocytes were 
assay-cd electrophysiologically for their response to 200 p?I 
acetylcholine (ACh) by the two-electrode voltage-clamp 
technique [43]. The results from a successful biocytin 
incorporation are shown in Figure 4. In this cxperimcnt, 
biocytin incorporation was successful at both positions a70 
and a76. Suppression with a natural amino acid (~~76. tyro- 
sine) and experiments using uncharged tRNA (tRNA- 
dCA) [28,29] were performed as controls. Clearly. the 
biotinylated mutants functioned at levels comparable to 
those for mutants suppressed with a natural amino acid. In 
addition, the very small currents arising from the dCA 
control (uncharged tRNA) demonstrate that the currents 
observed in the biocytin experiments arise solely from 
receptors containing the biotinylated amino acid. 
At five of the ten positions in the hlIR (a68, ~~70, a71, 
(~75 and a76), biocytin was incorporated efficiently into 
functional receptors with whole-cell currents ranging from 
several hundred to several thousand nA (Table 1). At the 
other five positions (~67, a69, 1~72, a73 and ~~74) whole- 





A schematic representation of the nAChR showing five homologous 
subunits in a roughly pentagonal array. Overall dimensions are taken 
from Unwin [38], but the arrangement of subunits is that advocated by 
a number of other workers [31,34,53]. The red bar on one of the 
a subunits denotes the approximate location of a main immunogenic 
region (MIR) [42]. 
the a70 biocytin mutant was expressed as a positive 
control so that whole-ccl1 currents, which often vary sub- 
stantially between oocytc batches, could be compared to 
an internal standard. A summary of these experiments is 
shown in Figure S.-Again, uncharged t-RNA MZS tested at 
all the sites as a control. In all cases the current e\.oked 
from 200 @I ACh was less than 20% of that obtained in 
Table 1 
Sequence analysis of the MIR from 34 nAChR a subunits in the 
SWISS-PROT database. 
Conservation ACh response with 
Position in cx subunits (o/o) biocytin incorporation 
Trp67* 97 - 
Asn68 56 + 
Pro69 79 
Asp70 26 + 
Asp71 53 + 
Tyr72* 91 
Gly73 47 - 
Gly74* 82 
Val75 62 + 
Lys76 44 + 
*Positions that have > 70% conservation across all nicotinic subunits 
(i.e. not solely CL subunits). ACh, acetylcholine. 
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Average whole-cell currents in response to 200 pM acetylcholine 
(ACh) for oocytes qected with nAChR ct70 TAG or a76 
TAG - 4:l :l :I, 1.2 ng -and uncharged tRNA, or tRNA charged with 
biocytln (Bio) or tyrosine (Tyr). The two bars for the a70 blocytin are 
the averages of the currents for the five lowest expressing oocytes 
(low) and the five highest expressing oocytes (hi). Error bars 
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Position of biocytin incorporatlon 
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I 
Whole-cell currents In response to 200 pM ACh from attempted 
blocytin suppression experiments at each of the ten posltions of the 
MIR of the nAChR. Results are normalized to the whole-cell current of 
n70 biocytin expressed in the same experiment. Bars represent the 
mean of two experiments, each with five oocytes. 
rhc suppression experiment, and in nine out of ten casts it 
\V;IS < 5% (data not shown). 
‘I‘hc clcctroph~siologr cvperiments clearly established the 
pl-cscncc of functional, bioqtin-conraining XCh receptors 
on rhe ooc\ te surface for five of the ten positions in the 
JlIK. Scqucncc consen.ation analysis of 34 nM:hR a sub- 
units shows that bioqtin produced functional rcccptors at 
fi\e of the six least conscr\wl positions in the RlIR 
(‘l’able 1). ‘l‘he fact that biocytin did not express well at the 
sixth position (&I>-73) may ark hccause a glycinc (side- 
chain molecular weight = 1) to hiocqin (sidechain molecu- 
lar weight = 298) muration may epitomize the phrase ‘non- 
conservati\c mutation’. t;urthermore, the four most highly 
conscrwzd residues, three of \vhich arc conserved 13~ > 70% 
across ~111 nicotinic subunits. are the positions at which bio- 
cbtin did no[ express. Because these four residues arc 
highly conscrccd. they may be crucial for the structure or 
function of the rcccptor and e\‘en non-conserc’ati\.c con- 
\cntional mutations may not bc mlerated. \Vc believe that 
the low currents obscr\wl for attcnipted biocytin incorpora 
tion ;ir these positions indicate that the relati~cly large 
sidechain of bioc?;tin is not tolerated at these positions. 
\Tith elcctrophysiologjcal cvidcnce for functional hiotinyl- 
arcd receptors, Me turn& our attention to the binding 
of strcpta\idin in order to assay the surface exposure of 
particular sidechains. To assay for strepal-idin binding. 
tutchcs of fi1.e oocytes, the whole-cell currents of which had 
prc\.iously been dctcrmined, were incubated in a solution 
of 300 phi “‘I-sucpta\ idin for 2 h and then washed esten- 
si\.cly (see \latcrials and mcthods section). Individual 
oocytcs c\ere measured in a ycountcr. Of the five mutants 
that shoved large lvhole-cell currcnIs, only one (a70 bio- 
cytin) showed strepta\idin binding 3bo\ c hackground 
Ic\~ls. In addition, no strepta\.idin binding \\:;Is obscr\ul 
with any of the five mutants that did not gi\ t‘ large \\ hole- 
cell currents or \\irh cells cxprcssing non-l,iotin~latec 
nA(%Ks. ‘I’hc results of a t\-pical expcrimcnt arc shown in 
Figure 6. 
In the cast of a70 biocytin. the mutant thar showcd strept- 
avidin binding. we also evaluated the binding of lz’I-labeled 
a-bungarotoxin - a snake toxin that is highly spwific for 
the nA(:hR. \\:c found that the amounts of strepta\~idin 
and a-bungarotoxin hound to 0.70 hioqtin uere similar. 
suggesting that vll nAChRs uzrc completel>- labeled t)); 
both a-bungarotoxin and streptavidin (data not shown). 
‘I’his also prwides concrete biochemical uidcnce to 
support the clcctrophysiological et idcncc that the ill s,iw 
suppression method produces full-length protcin incorpo- 
rating only rhe &sired amino acid. If this lvcrc not the 
USC (i.e. if sonic n:\(:hR \vas produced with a natural 
amino acid incorporated at the suppression site as a result 
of read through of the srop codon or reacylation of the 
tRKA), WC wor~ld hahe expectcd the amount of rA>ungaro- 
toxin binding to exceed the amount of strcptak~in binding. 
‘1’0 explore whcthcr the streptavidin-binding sires and 
a-bungarotoxin-binding sitcs overlap, \vc incubated oocytcs 
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1251-Streptavidin binding to oocytes injected with nAChR cc70 TAG or 
ct76 TAG and uncharged tRNA (dCA) or tRNA charged with biocytin 
(Bio) or tyrosine (Tyr). The oocytes used in this experiment are identical 
to those whose whole-cell currents are shown in Figure 4, 
demonstrating that binding of streptavidin correlates with whole-cell 
current. The ct76Tyr mutation establishes that streptavidin does not 
bind to non-biotinylated nAChRs. Detector background has been 
subtracted in all cases. Error bars are f s.e.m. (n = 5). 
expressing nAChR a70 biocytin with unlabeled streptavi- 
din. We then applied lZ”I-a-bungarotoxin to these oocytes 
to determine if it could still bind. QT:e also performed the 
reverse experiment, incubating oocytes expressing nAChR 
a70 biocytin with unlabeled a-bungarotoxin and attempt- 
ing to bind “‘I-streptavidin. The results of these expcri- 
merits are shown in Figure 7. These results clearly dem- 
onstrate that binding of a-bungarotoxin does not strongly 
inhibit binding of streptavidin to the a70 biocytin mutant 
and aire versa. This is consistent with previous studies, 
which demonstrated that both a-bungarotoxin and antibod- 
ies against the MIR are capable of binding simultaneousl) 
to the intact receptor [44]. 
Finally, we have measured the EC,,, value (the dose at 
which 50% activation is seen) for ACh for the a70 biocytin 
mutant both before binding streptavidin (EC,, -39 PM) 
and after binding (EC,,, -34 PM). These values are not 
significantly different from one another, nor are they 
significantly different from the EC,,, value of the wild- 
type receptor (49 yM). At first it may seem surprising that 
the binding of a large protein to the receptor would not 
alter its pharmacological behavior, but previous studies 
have shown that antibodies binding to the MIR do not 
substantially alter the physiology of the receptor [45]. 
To gain a clearer physical picture of the above results, we 
have considered them in light of a previously published 
structural model. Tsikaris ttal. [46] used nuclear magnetic 
Btx* Stp + Btx* stp* Btx + Stp* 
Whole-cell blnding of lz51-streptavidin and ‘251-cc-bungarotoxin to AChR 
11x70 biocytin mutants. Btx’, binding lz51-a-bungarotoxin to untreated 
oocytes; Stp + Btx*, binding ‘251-a-bungarotoxin to oocytes pretreated 
with streptavidin; Stp*, binding lz51-streptavidin to untreated oocytes; 
Btx + Stp*, binding ‘251-streptavidin to oocytes pretreated with 
cc-bungarotoxin. Within the error bars shown, the data demonstrate 
that ‘251-cc-bungarotoxin and lz51-streptavidin do not interfere with one 
another in blnding to the a70 biocytin nAChR. Bindlng is expressed as 
counts per minute per PA of whole-cell current, to account for different 
expression levels between groups of oocytes. Counts have been 
normalized to account for the differences in specific activity between the 
‘251-streptavidin and “%a-bungarotoxin. Error bars are f s.e.m. (n = 5). 
resonance (NhIR) spectroscopy to determine the structure 
of a ten residue peptide corresponding to the sequence of 
the hIIR from the a subunit of the 7iltp& u~Nl$orniu 
nXChR. This sequence differs from that of the mouse 
muscle hIIR studied here at two sites - Ala70 and Ile75. 
Starting with the coordinates for the Torpdo hlIR taken 
from the Protein Data Bank [47,48], we alter& the 
sidechain identities of these two residues to the corre- 
sponding mouse muscle residues (aspartate and saline. 
respectively) using standard geometries. The resulting 
structure is shown in Figure 8. The structure leads natu- 
rally to a rationalization of our results. ‘I’he hIIR peptide 
clearly has two sides - one that can tolerate biocytin and 
one that cannot. Biocytin is larger than any of the 20 
natural amino acids. so perhaps it will produce functional 
receptors only if there is a preexisting (or easily created) 
open space for its larger sidechain. We suggest that the 
‘blue’ side has this open space, and so presumably faces 
away from the bulk of the protein. In contrast, the ‘purple’ 
side cannot tolerate biocytin and so apparently the sidc- 
chains on this face project down into the rest of the protein. 
The selectivity of the biocytin method is shown by the 
result that biocytin was incorporated at five sites without 
loss of channel function and yet only one of these sites \vas 
competent to bind streptavidin under the conditions of 
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Figure 8 
A schematic of the structure of the Torpedo 
MIR protein with modifications Ala70-tAsp 
and lle75+Val. Purple, sites at which biocytin 
Incorporation was unsuccessful (~~67, n69, 
~72, a73 and 1~74); blue, sites that 
incorporated biocytin, but did not bind 
streptavidin (~68, ~1x71, a75 and 1~76); red, 
the sole streptavidin-binding site (~~70). The 
right-hand view is derived from the left-hand 
view by a 180” rotation around a vertical axis. 
I 
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these experiments. The crystal structure of the biotin- 
streptavidin complex reveals that the ligand is buried fairly 
deeply in the protein, with even the terminal carboxylate 
not fully exposed [49]. Only residues that position the bio- 
cytin in an unencumbered environment will therefore lead 
to strcpta\idin binding. As shown in Figure 8, the Asp70 
sidcchain points ‘up’ and therefore akvay from, for 
example, the Trp67 or ‘l’yr72 sidechains that arc postu- 
latcd to project down into the receptor. ‘l’hc other biotin- 
incorporating sidechains project approximately normal to 
the r\sp70 sidechain. Apparently, these sites (&I#, ~171, 
a7.5, and ~176) point to a space that is large enough for hio- 
cytin but not for streptavidin. There is precedent for 
binding interactions significantly lveaker then lOPI” IL-’ 
for substituted hiotins [SO], so perhaps higher streptavidin 
concentrations would have allowed detectable binding at 
the hiotin-incorporating sites. Such studies were not feasi- 
ble. however, due to non-specific binding of streptavidin 
to the oocytes at higher concentrations. 
In summar). our results suggest a particular orientation for 
the 1\IIR of the nAChR. Residue a70 points directly out 
and alvay from the receptor. The sidechains emanating 
from residues 1~67, ~~69, and (~72 ((x73 and (~74 are glycines 
with effectively no sidechain) project down into the 
protein. The remaining residues, c&3, a71. (x75, and a76, 
project into open space, hut perhaps towards some other 
structural feature of the receptor that prevents streptavidin 
binding. This analysis implies that a tether longer than is 
present in biocytin might allow streptavidin binding at the 
hiotin-incorporating sites. LfTe therefore prepared two 
longer chain analogs of bioqtin, A and B (Figure 9). ITnfor- 
tunately, u-e were not able to incorporate the longest 
analog, B, into functional receptors. \Ve could incorporate 
bioc>-tin-analog ‘-2 at position a70 at levels that were readil) 
detectable by electrophysiology (500-1000 nA). This is a 
remarkably ‘unnatural’ amino acid, suggesting considerable 
flexibility in the ribosomal machinery. The amount of 
expression achieved \\as not sufficient for the less scnsitivc 
streptalidin assay, howei-er, and a-e were not, therefore. 
able to make USC of the longer chain analog. 
We conclude that the method of site-specific hiocytin 
incorporation with strepta\,idin detection pro\-ides a 
potentially general 1x-a); to identify- highI>- sllrface-exposed 
residues in complex, integral membrane proteins. It thus 
provides information that goes hcyond the ‘simpler’ ques- 
tion of transmembrane topology. \Yc look for\% ard to 
applying this approach to other channels, receptors, and 
transporters. Our data also show that biocytin derivatives 
with longer tethers do not express lvcll. so the biocytin 
method alone cannot bc simply generalizcd to a n-i& 
range of exposures. Alternative strategies can bc cnli- 
sioned, perhaps in\.ol\-ing incorporation of unnatuml 
residues which are rather small hut \vhich hale specific 
reactivities allowing attachment of biotin moieties u ith 
longer chains. 
Significance 
Direct methods for determining the degree of exposure 
of individual residues in functional membrane proteins 
expressed in living cells would yield significant insight 
into membrane protein structure. Evaluation of the 
exposure also yields information about the transmem- 
brane topology and more subtle variations in the intra- 
cellular and extracellular surface accessibility. The i~z 
viva nonsense suppression method for the incorporation 
of unnatural amino acids into proteins is a powerful 
tool for obtaining atomic-scale information about func- 
tional proteins expressed in Xenopz4.s oocytes. We have 
extended the method to allow incorporation of a biotinyl- 
ated amino acid site-specifically within the main immuno- 
genic region (MIR) of the nicotinic acetylcholine receptor 
(nAChR), the prototypical ligand-gated ion channel. 
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Figure 9 
A 
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Two longer chain analogs of biocytin, A and B, that were used in an 
attempt to assess streptavidin binding. 
IJsing i2”1-labeled streptavidin as a probe, we have been 
able to identify an amino acid in the MIR that is highly 
exposed on the surface of the nAChR. We believe that 
this method represents an improvement over previous 
approaches for determining surface exposure and trans- 
membrane topology for a number of reasons: the method 
does not require purified protein; it uses a minimally per- 
turbing point mutation; it uses a marker that is not 
endogenous to either the protein of interest or to other 
cell-surface proteins; it allows detection by a commer- 
cially available assay; and it determines the topology and 
surface exposure in a functional, characterizable protein 
expressed in viva. Thus, we consider the method to be 
a potentially general one for determining the surface 
exposure of specific residues of transmembrane proteins 
expressed in z&o. In a broader sense, these results dem- 
onstrate the power of the in vivo nonsense suppression 
method for applying the tools of organic chemistry to 
the problems of molecular neuroscience. 
Materials and methods 
Reagents were purchased from Aldrich unless otherwise noted. 
(3-[‘2511-iodotyrosy154)~-bungarotoxin (2000 mCi/mmol) and [‘251]-strep- 
tavidin (30 mCi/mg) were purchased from Amersham. Anhydrous THF 
was distilled from Na/benzophenone; anhydrous DMF was obtained 
from Aldrich. All chemical syntheses were performed under a positive 
pressure of argon unless noted otherwise. NMR spectra were recorded 
on a General Electric QE300 (300 MHz ‘H, 75 MHz I%), JEOL Delta 
400 (100 MHz, r3C), or a Bruker AM-500 (500 MHz ‘H, 125 MHz ‘%) 
spectrometer and are referenced to residual solvent protons. Mass 
spectrometry (FAB) was performed by the mass spectrometry facilities 
at the University of California, Riverside, USA or at Caltech, CA, USA. 
Ultra-violet/visible (UV/vis) spectra were recorded on a Beckman Instru- 
ments DU-640 continuous-wave spectrometer. High performance liquid 
chromatography (HPLC) separations were performed on a Waters dual 
510 pump liquid chromatograph system equipped with either a Waters 
490E variable wavelength UV detector or a Waters 960 photo diode 
array detector. Analytical HPLC samples were separated using a Waters 
NovaPak Cl 8 column (3.9 x 150 mm); semi-preparative samples were 
separated using a Whatman Magnum 9 column (9.4 x 500 mm, Partisil 
10, ODS-3). Oligonucleotides for mutagenesis were synthesrzed by the 
Bropolymer Synthesis Facility at Caltech. Polymerase chain reactions 
(PCR) were performed using a Perkin-Elmer TC-1 DNA Thermal Cycler. 
Automated sequencing of PCR products was performed by the DNA 
Sequencing Core Facility at Caltech. Ligation of aminoacyl-dCA to 
tRNA-THG73(-CA) was performed as described previously [29]. 
NVOC-biocytin cyanomethyl ester 
Biocytin (50 mg, 0.13 mmol, Molecular Probes) and sodium carbonate 
(28 mg, 0.27 mmol) were dissolved with stirring in water (7.5 ml) and 
freshly distilled THF (5 ml). A solution of 6nitroveratryloxycarbonyl 
chloride (NVOC-Cl) (37 mg, 0.13 mmol) In 5 ml THF was added drop- 
wise [30,51]. After 3 h, solvents were removed in vacua and the 
remaining residue was dissolved in dry DMF (1.5 ml) and chloroaceto- 
nitrile (1.5 ml). Triethylamine (400 ul) was added and the mixture was 
stirred overnight. Volatiles were removed NI vacua and the remaining 
solid was purified by flash chromatography (silica gel, CH,CI, + MeOH 
l-l 0%) to give 67 mg of NVOC-biocytin cyanomethyl ester as a pale 
yellow solid (77% yield for 2 steps): ‘H NMR (500 MHz, DMSO-de) 
F 8.10 (d-br, J = 6.8 Hz, 1 H), 7.74 (t-br, J = 5.0 Hz, 1 H), 7.70 (s, 1 H), 
7.18 (s, IH), 6.39 (s, lH), 6.33 (s, lH), 5.38 (AB, J= 15.0 Hz, lH), 
5.34 (AB, J= 15.0 Hz, lH), 5.01 (s, 2H), 4.27 (m, lH), 4.11 (m, lH), 
3.92 (s, 3H), 3.86 (s, 3H), 3.13 (m, 1 H), 3.04 (m, 1 H), 2.99 (m, 2H), 
2.80 (dd, J= IO Hz, 5.5 Hz, lH), 2.57-2.46 (m, 3H), 2.03 (t, 2H), 1.70. 
1.15 (m, IOH); 13C NMR (75 MHz, DMSO-de) 6 172.0, 171.6, 162.8, 
155.8, 153.5, 147.8, 139.2, 127.8, 115.8, 110.3, 108.2, 62.8, 61.1, 
59.3, 56.3, 56.1, 55.5, 53.6, 49.5, 39.9, 38.1, 35.3, 30.2, 28.7, 28.3, 
28.1, 25.4, 22.8. 
a-NVOC-E-(6-(biotinoyl)amino)hexanoyl-L-iysine (NVOC-A) 
A solution of cc-NVOC-lysine (42 mg, 0.1 1 mmol, 1 .O equivalent, pre- 
pared in two steps from s-Boc-lysine and NVOC-Cl, followed by 
removal of the Boc-group wrth TFA), 6-((biotinoyl)amrno)caproic acrd 
N-hydroxysuccinimide ester (50 mg, 0.1 1 mmol, 1 .O equivalent, Mol- 
ecular Probes) and Na,CO, (47 mg, 0.44 mmol, 4.0 equivalent) was 
stirred in dry DMF (5 ml) under argon. After 3 days, the mixture had 
become gel-like and a solutron of 1 N NaHSO, (50 ml) was added, fol- 
lowed by CH,CI, (50 ml). The mixture was stirred and a pale yellow 
precipitate formed. The solid was filtered, washed with CH,CI,, water, 
acetone, and dried to give 42 mg of a pale yellow solid (53% yield): ‘H 
NMR (500 MHz, DMSO-d,) 6 7.74 (d-br, J = 8 Hz, 1 H), 7.66 (m, 2H), 
7.64 (s, 1 H), 7.12 (s, 1 H), 6.39 (s, 1 H), 6.33 (s, 1 H), 5.33 (AB, 
J= 15.1Hz, lH), 5.25 (AB, J= 15.1 Hz, IH), 4.23 (t, J=5.5 Hz, lH), 
4.06 (m, lH), 3.85 (s, 3H), 3.80 (s, 3H), 3.02 (m, lH), 2.93 (m, 4 H), 
2.82 (s, lH), 2.76 (m, IH), 2.73 (s, IH), 2.50 (d, J = 12.4 Hz, lH), 
1.94 (m, 4H), 1.63 (m, lH), 1.52 (m, 2H), 1.37 (m, 4H), 1.28 (m, 8H), 
1.15 (m, 2H); i3C NMR (100 MHz, DMSO-d,) 6 173.8, 171.9, 171.8, 
162.7, 155.8, 153.5, 147.6, 139.0, 138.1, 128.2, 110.0, 108.1, 62.4, 
61.0, 59.2 56.2, 56.1, 55.4, 53.8, 38.3, 38.1, 35.4, 35.2, 30.4, 28.9, 
28.7, 28.2, 28.0, 26.1( 25.3, 25.0, 23.0. 
(x-NVOC-&-(6.(biotinoyl)amino)hexanoyl-L-lysine cyanomethyl 
ester 
To a solutron of cr-NVOC-f-(6.(brotinoyl)amino)hexanoyl-L-lysine (40 mg, 
0.055 mmol, 1 .O equivalent) in 2 ml dry DMF was added triethylamine 
(24 ul, 0.165 mmol, 3.0 equivalents) and chloroacetonitrile (2 ml). After 
stirrrng for 9 h under argon, volatiles were removed in vacua and the 
remaining solid was partitioned between water and CH,CI,. A pale 
yellow solid remained and was combined with the organic fraction, 
concentrated and dried in vacua to afford the cyanomethyl ester as a 
pale yellow solid (20 mg, 47%): ‘H NMR (500 MHz, DMSO-de) 6 8.07 
(d, J = 7.5 Hz, 1 H), 7.70 (m, 2H), 7.18 (s, 1 H), 6.39 (s, 1 H), 6.33 (s, 
IH), 5.38 (AB, J= 14.8 Hz, lH), 5.34 (AB, J= 14.8 Hz, IH), 5.01 (s, 
2H), 4.29 (t, J= 5.6 Hz, IH), 4.12 (m, 2H), 3.92 (s, 3H), 3.86 (s, 3H), 
3.08 (m, lH), 2.97 (m, 4H), 2.80 (s, lH), 2.57-2.49 (m, 2H), 2.01 (m, 
4H), 1.63 (m, 1 H), 1.43 (m, 4H), 1.34 (m, 8H), 1 .17 (m, 2H). 
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ol-NVOC-&-(6-((6-((biotinoyl)amino)hexanoyl)amino)hexanoyl)- 
L-lysine (NVOC-B) fluorenylmethyl ester 
A mixture of 6-((6.((biotinoyl)amino)hexanoyl)amino)hexanoic acid, suc- 
cinimidyl ester (50 mg, 0.088 mmol, 1 equivalent) and a-NVOC-lysine 
fluorenylmethyl ester (75 mg, 0.13 mmol, 1.5 equivalents; [52]) was 
stirred in dry DMF (1 ml) with triethylamine (25 pl, 2 equivalents). The 
reaction was stirred for 4 days after which time the volatiles were 
removed and the yellow residue was purified by column chromatogra- 
phy (silica, 4:l CH,CI,:MeOH) to afford 46 mg of the desired product 
(47% yield): ‘H NMR (500 MHz, DMSO-da) 6 7.92-7.84 (m, 3H), 7.69. 
7.55 (m, 6 H), 7.36 (q, J = 7.6 Hz, 2H), 7.25 (m, 2H), 7.13 (s, lH), 
6.35 (s, lH), 6.30 (s, lH), 5.34 (A/3, J = 13.5 Hz, lH), 5.28 (A@ 
J= 13.5 Hz, lH), 4.45 (m, lH), 4.38 (m, lH), 4.23 (m, lH), 4.19 (t, 
J = 5.0 Hz, lH), 4.07 (m, lH), 3.89 (q, J = 7.0 Hz, lH), 3.84 (s, 3H), 
3.80 (s, 3H), 3.05 (m, lH), 2.75 (m, lH), 1.97 (m, 6H), 1.65-1.20 (m, 
26H); ‘sC NMR (125 MHz, DMSO-d,) 6 172.0, 171.6, 171.5, 162.4, 
155.5, 153.2, 147.5, 144.0, 143.4, 140.5, 139.0, 127.5, 127.4, 
126.8, 124.7, 119.8, 110.3, 108.0, 65.5, 62.2,60.8, 59.0, 55.9, 55.9, 
55.1, 53.7, 46.1, 40.3, 38.0, 37.8, 35.1, 35.0, 29.9, 28.7, 28.4, 27.9, 
27.7, 25.9, 25.0, 24.8, 22.5. 
ol-NVOC-&-(6-((6-((biotinoyl)amino)hexanoyl)amino)hexanoyl)- 
L-lysine cyanomethyl ester 
a-NVOC-&-(6-((6-((biotinoyl)amino)hexanoyl)amino)hexanoyl)-L-lysine 
fluorenylmethyl ester (19 mg, 0.02 mmol, 1 equivalent) was dissolved in 
dry DMF (1 ml). Piperidine (20 ul, 10 equivalents) was added and the 
mixture was stirred. After 2.5 h, volatiles were removed in vacua, 
hexane (15 ml) was added, and the suspension was filtered. The 
remaining solid was dissolved in aqueous DMF. The solution was 
lyophilized and the solid residue was dissolved in dry DMF (4 ml), 
chloroacetonitrile (0.8 ml) and triethylamine (100 ~1). After 24 h, the 
mixture was separated using preparative HPLC with a linear gradient of 
100% 10 mM aqueous acetic acid to 100% acetonitrile over 1 h. The 
product-containing fractions were lyophilized to give 5 mg of a pale 
yellow solid (31% yield for 2 steps): ‘H NMR (500 MHz, DMSO-d,) 6 
8.08 (d, J=7.5 Hz, lH), 7.95 (s, lH), 7.18 (s, lH), 6.40 (s, lH), 6.34 
(s, 1 H), 5.40 (A/3, J = 14.8 Hz, 1 H), 5.35 (AB, J = 14.8 Hz, 1 H), 5.01 
(s, 2H), 4.31 (m, 1 H), 4.12 (m, 2H), 3.92 (s, 3H), 3.86 (s, 3H), 3.07 (m, 
lH), 2.98 (m, 6 H), 2.88 (s, lH), 2.80 (dd, J=7.3, 5.2 Hz, lH), 2.72 
(s, lH), 2.57 (d, J=12.4 Hz, lH), 1.75-1.52 (m, 4H), 1.50-1.41 (m, 
6H), 1.41-1.25 (m, 8H), 1.25-1.12 (m, 4H); 13C NMR (125 MHz, 
DMSO-dd 6171.8, 171.7, 171.3, 162.5, 162.2, 155.6, 153.4, 148.6, 
139.3, 127.5, 115.5, 110.5, 108.3,66.9, 62.5, 61.0, 59.1, 56.1,56.1, 
55.2, 53.5, 49.7, 49.3, 44.2, 38.2, 37.9, 35.6, 35.3, 35.1) 30.7, 28.8, 
28.5, 28.0, 27.9, 26.0, 25.2, 24.9, 24.8, 22.6. 
General method for coupling of N-protected amino acids to dCA 
This method is essentially as described [26,301. The N-protected 
amino acid (-30 pmol, 3 equivalents) was mixed with the tetra-n-butyl- 
ammonium salt of the dCA dinucleotide (- 10 umol, 1 equivalent) in dry 
DMF (400 ~1). The reactions were monitored by analytical HPLC with a 
linear gradient of 100% 25 mM aqueous ammonium acetate buffer 
(pH 4.5) to 100% acetonitrile over 1 h. Following the disappearance of 
the dCA (5 min to 3 h), the reaction mixture was separated using semr- 
preparative HPLC with a linear gradient of 100% 25 mM aqueous 
ammonium acetate buffer (pH 4.5) to 100% acetonitrile. The fractions 
containing the aminoacyl dinucleotide were collected and lyophilized. 
The lyophilized solid was redissolved in 10 mM aqueous acetic 
acid/acetonitrile and lyophilized a second time to remove salts. The 
products were characterized by UV/vis and mass spectrometry. 
dCA-NVOC-biocytin 
Prepared as above: FAB-MS [M-HI- 1228, calc’d for C,,H,,N,,O,,- 
P,S 1228; UV h,,, (10 mM aqueous acetic acid) 258 nm, 350 nm. 
dCA-or-NVOC-&-(6-(biotinoyl)amino)hexanoyl-L-lysine 
Prepared as above: FAB-MS [M-H]- 1342, calc’d for C,, H72N,4023P2S 
1342; UV h,, (10 mM aqueous acetic acid) 256 nm, 350 nm. 
dCA-a-NVOC-&-(6-((6-((biotinoyl)amino)hexanoyl)amino)- 
hexanoyl)-L-lysine 
Prepared as above: ESI-MS [M+Na]+ 1480, calc’d for C,,H,,N,,O,,- 
P,SNa 1480; UV h,,, (10 mM aqueous acetic acid) 253 nm, 350 nm. 
Site-directed mutagenesis of the AChR n67-76 TAG mutants 
The mouse muscle AChR a67-76 TAG mutants were prepared using a 
standard two step PCR-based cassette mutagenesis procedure using 
pfu Polymerase (Stratagene). For each mutant, a trimmed BsmBI-!&cl 
PCR-generated fragment was subcloned into the dephosphorylated 
BsmBI-Mscl fragment of mouse muscle AChR a subunit in the pAMV- 
PA vector 1281. When possible, silent mutatrons were introduced to 
facilitate screening of positive colonies by restriction endonuclease 
digestion. We have found the Bfal recognition sequence CTAG to be 
particularly helpful for screening. All mutants were verified by automated 
sequencing of the entire PCR cassette across both ligation sites, 
In vitro transcription of mRNA 
mRNA was synthesized in vitro from Noel linearized plasmid DNA 
(1 pg/20 PI reactron) using the T7 MessageMachine kit from Ambion as 
described in the manufacturer’s instructions. The products were puri- 
fied by phenol:chloroform:isoamyl alcohol extraction and isopropanol 
precipitation. Purity of the mRNA was assayed by gel electrophoress. 
Oocyte preparation and injection 
Oocytes were removed from Xenopus laevis as described previously 
[43] and maintained at 18°C in ND96 solution consisting of 96 mM 
NaCI, 2 mM KCI, 1 mM MgCI,, 1.8 mM CaCI,, 5 mM HEPES (pH 7.5), 
supplemented with sodium pyruvate (2.5 mM), gentamicin (50 yg/ml), 
theophylline (0.6 mM) and horse serum (5%). Prior to mrcroinjection, 
the NVOC-aminoacyl-tRNA (1 ug/yl in 1 mM NaOAc, pH 5.0) was 
deprotected by Irradiating the sample for 5 min with a 1000 W xenon 
arc lamp (Oriel) operating at 600 W equipped with WG-335 and 
UG-1 1 filters (Schott). The deprotected aminoacyl-tRNA was mixed 
1 :l with a water solution of the desired mRNA. Oocytes were injected 
with 50 nl of a mixture containing 25 ng aminoacyl-tRNA and 1.2 ng of 
total mRNA (4:l :l :l a$:y:S subunit storchiometry). 
Electrophysiology 
Two-electrode voltage clamp measurements were performed 36-48 h 
after injection using a GeneClamp 500 amplifier (Axon Instruments, 
Foster City, CA, USA). Microelectrodes were filled with 3 M KCI and 
had resistances of 0.5-2 MQ Oocytes were perfused with a nominally 
calcium-free bath solution containing 96 mM NaCI, 2 mM KCI, 1 mM 
MgCI,, 5 mM HEPES (pH 7.5). Macroscopic ACh-Induced currents 
were recorded in response to application of 200 uM ACh at a holdrng 
potential of -80 mV. Whole cell current measurements are reported as 
the mean f standard error. 
General procedure for radioactive ligand-binding experiments 
Batches of five oocytes were incubated at room temperature for 15 min 
with gentle agitation in 400 ul calcium-free ND96 (see Electrophysrol- 
ogy section) containing 10 mg/ml BSA (FractionV, Sigma). The radio- 
active ligand was then added to a final concentration of 300 pM for 
1251-streptavidin (Amersham, 30 uCi/ug) or 1 nM for 1251-a-bungarotox~n 
(Amersham, 2000 CiJmmol). After 2 h, the oocytes were transferred to 
an ice-cold solution of ND96 + 10 mg/ml BSA (1.5 ml) and agitated for 
5 min. The oocytes were then washed extensively in fresh solutions of 
ice-cold ND96 + BSA and transferred individually to scintillation vials 
and counted in a Beckman LS5000 y-counter. In all cases, a sample of 
the final wash solution was counted to ensure that unbound ligand had 
not been carried through the assay. In addition, five empty scintillation 
vials were counted in each experiment to determine the detector back- 
ground which was then subtracted from subsequent measurements. In 
experiments involving the binding of both labeled and unlabeled ligand, 
the unlabeled ligand was added at high concentration (166 nM for 
streptavidin, 312 nM for bungarotoxm) to the initial 400 1.11 solution, After 
20min, the labeled ligand was added and the assay proceeded as 
described above. 
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